Revenue, 2025
USD 113.41 Billion
Forecast, 2035
USD 336.82 Billion
CAGR, 2025 - 2035
11.50%
Report Coverage
United Kingdom
United Kingdom Biotechnology Market Size and Trends for 2026
The UK biotechnology market is set to grow from USD 113.41 billion in 2025 to USD 336.82 billion by 2035, with an expected CAGR of 11.50% over the forecast period from 2025 to 2035.
Quick Facts
- Biotechnology market to cross USD 1962.93 billion by 2026.
- North America was the largest contributor to the market by 40.49% share in 2025.
- Asia-Pacific is estimated to exhibit the fastest growth by 14.80% in the market over the upcoming years.
- By technology, the DNA sequencing segment led the global market in 2025.
- By technology, the nanobiotechnology segment is predicted to witness significant growth in the market over the forecast period.
- By application, the bio-pharmacy segment held a dominant presence in the market in 2025 and is projected to expand rapidly in the market in the coming years.
- According to Steve Jobs, the most significant advancements of the 21st century would arise from the convergence of biology and technology.
What Drives the Growth of the Global Biotechnology Market?
The biotechnology market refers to the industry that uses living organisms or biological systems to develop new products, services, and technologies for healthcare, agriculture, industrial applications, and other fields. This market encompasses a wide range of sectors, including biopharmaceuticals, biotechnology research and development, bioprocessing, genomics, proteomics, bioinformatics, and synthetic biology.
The global biotechnology market has been growing rapidly in recent years, driven by a number of factors such as increasing demand for innovative treatments for chronic diseases, rising investments in research and development, advances in technology, and increasing government support. Biotechnology research and development often involves genetic engineering, gene editing, and other advanced techniques to modify or manipulate living organisms to produce desired traits or outcomes. Biotechnology has revolutionized many industries and has the potential to address some of the world’s most pressing challenges, such as disease, hunger, and climate change.
The biotechnology market is witnessing significant growth due to the increasing demand for food, the rising prevalence of chronic diseases, advancements in technology, and growing government initiatives to support biotechnology research. The market is expected to witness further growth during the forecast period driven by the biopharmaceuticals segment, DNA sequencing technology, and increasing investments in biotechnology research and development.
Biotechnology Market Top Companies
- Lonza
- AstraZeneca
- Pfizer Inc.
- Gilead Sciences Inc.
- F. Hoffmann-La Roche Ltd.
- Biogen
- CELGENE Corporation
- Sanofi
- Abbott
- Novartis AG
Market Segments
By Application
- Bio-pharmacy
- Monoclonal antibodies
- Vaccines
- Recombinant proteins
- Gene & cell therapies
- Biosimilars
- Bio-industries
- Industrial enzymes
- Bio-based chemicals
- Biofuels & bioplastics
- Fermentation products
- Bioremediation
- Bio-services
- CRO & CDMO services
- Analytical & testing services
- Genomics & proteomics services
- Regulatory & compliance services
- Bio-agriculture
- Genetically modified crops
- Biofertilizers & biopesticides
- Plant tissue culture
- Seed biotechnology
- Animal biotechnology
- Bio-informatics
- Sequence analysis tools
- Genome annotation platforms
- Systems biology software
- Clinical bioinformatics
- AI-driven biological data analytics
By Technology
- Fermentation
- Batch & fed-batch fermentation
- Continuous fermentation
- Industrial & microbial fermentation
- Tissue Engineering & Regeneration
- Stem cell technologies
- 3D bioprinting
- Scaffold-based regeneration
- Regenerative biomaterials
- PCR Technology
- Conventional PCR
- Real-time PCR (qPCR)
- Digital PCR
- RT-PCR
- Nanobiotechnology
- Nano drug delivery systems
- Nano-diagnostics
- Nanobiosensors
- Chromatography
- Liquid chromatography (HPLC/UPLC)
- Gas chromatography
- Affinity & ion-exchange chromatography
- DNA Sequencing
- Sanger sequencing
- Next-generation sequencing (NGS)
- Whole genome & targeted sequencing
- Cell-Based Assay
- Cytotoxicity assays
- Cell viability assays
- Reporter gene assays
- High-content screening
- Others
- CRISPR & gene editing
- Proteomics & metabolomics
- Synthetic biology
- Microfluidics
Tables & Figures
List of Figures & Tables
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@towardshealthcare.com
Our Client
United Kingdom Biotechnology Market to Reach USD 336.82 Billion by 2035
The United Kingdom biotechnology market is projected to expand from USD 126.45 billion in 2026 to USD 336.82 billion by 2035, with a CAGR of 11.50%.